NovaDel Pharma Continuing to Explore Strategic Alternatives

Published: Jan 19, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--NovaDel Pharma Inc. (OTCBB: NVDL), a specialty pharmaceutical company that develops oral spray formulations of marketed pharmaceutical products, today announced that, as previously disclosed, it is continuing to explore various strategic alternatives for the Company, including selling the Company or some or all of its pharmaceutical products or license rights, or raising capital for the Company through a financing transaction.

Back to news